| Jason Brent Jordan, DMD | |
|
279 5th Ave, Ashville, AL 35953 | |
| (205) 594-5044 | |
| (205) 594-5044 |
| Full Name | Jason Brent Jordan |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 279 5th Ave, Ashville, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720180813 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 5192 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jason Brent Jordan, DMD Po Box 129, Ashville, AL 35953 Ph: (205) 594-5044 | Jason Brent Jordan, DMD 279 5th Ave, Ashville, AL 35953 Ph: (205) 594-5044 |
News Archive
Biophysicists have developed a method for modifying the surface of micro- and nanoparticles — tiny structures measuring between a thousandth and a millionth of a millimeter — by covering them with biological molecules. Engineered in this way, the particles can serve as both therapeutic and diagnostic agents, delivering drugs to cancer cells.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that based on information provided by PharmAthene in its compliance plan, and discussions with Exchange staff, the NYSE Amex LLC has determined that the Company made a reasonable demonstration of its ability to regain compliance with the NYSE Amex listing requirements and granted PharmAthene an extension until January 26, 2012 to demonstrate its compliance.
Spotless surfaces in hospitals can hide bacteria that rarely cause problems for healthy people but pose a serious threat to people with weakened immune systems.
Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye.
Given that cancer is a disease caused by gene mutations, cancer researchers have been striving to develop gene therapies aimed at correcting these mutations. However, these efforts have been hobbled by the difficulty in safely and efficiently delivering anticancer genes to tumors. Nanoparticles, however, may solve these delivery issues, and two recently published studies, using two different types of nanoparticles, lend credence to that hypothesis.
› Verified 3 days ago
Dr. Joseph W Labbe, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 125 Medical Circle, Ashville, AL 35953 Phone: 205-594-5171 Fax: 205-594-7311 |